INOVIO PHARMACEUTICALS, INC. Impairment of Intangible Assets (Excluding Goodwill)
INOVIO PHARMACEUTICALS, INC. (INO) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2024-03-06
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-06-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-03-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2022 was $0.00.
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2021 was $0.00.
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2020 was $0.00.
- INOVIO PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2019 was $0.00.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 10-K · filed 2024-03-06 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 10-K · filed 2024-03-06 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-12 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-12 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-14 | |||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |